Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.72 |
| ▸ | HPGD | P15428 | 9/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.64 |
| ▸ | RAB9A | P51151 | 3/20 | 0.64 |
| ▸ | TSHR | P16473 | 2/20 | 0.64 |
| ▸ | NPC1 | O15118 | 2/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 4/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | GAA | P10253 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5079305 | 0.84 | TDP1 (0.62) | MAPTHPGDSMN1; SMN2TSHRMEN1 | |
| SCHEMBL12998521 | 0.84 | MAPT (1.00) | MAPTHPGDSMN1; SMN2RAB9ATSHR | |
| SCHEMBL25394140 | 0.83 | MAPT (0.67) | MAPTHPGDSMN1; SMN2RAB9ATSHR | |
| SCHEMBL1090743 | 0.82 | MAPT (0.74) | MAPTHPGDSMN1; SMN2RAB9ATSHR | |
| Hydrochloric Acid SCHEMBL29433236 | 0.82 | MAPT (0.66) | MAPTHPGDSMN1; SMN2RAB9ATSHR | |
| SCHEMBL8389330 | 0.81 | MAPT (0.73) | MAPTHPGDSMN1; SMN2RAB9ATSHR | |
| SCHEMBL27401045 | 0.81 | MAPT (0.72) | MAPTHPGDSMN1; SMN2RAB9ATSHR | |
| SCHEMBL29364868 | 0.81 | RAB9A (0.78) | MAPTHPGDSMN1; SMN2RAB9ATSHR | |
| SCHEMBL116448 | 0.81 | RAB9A (0.78) | MAPTHPGDSMN1; SMN2RAB9ATSHR | |
| SCHEMBL29435284 | 0.80 | ALDH1A1 (0.78) | MAPTHPGDSMN1; SMN2RAB9ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250024837-A1 | PESTICIDE SYSTEM | BANISH, MICHELE | 2025-01-23 | — | — | US | disclosed |
| US-20240074434-A1 | COMPOSITION INCLUDING EFFERVESCENT AGENTS, BIOSTIMULANT, NUTRIENT, AND PESTICIDE | ROBBINS JEFFREY HANSON (US) | 2024-03-07 | — | — | US | disclosed |
| US-20240065262-A1 | COMPOSITION INCLUDING EFFERVESCENT AGENTS, BIOSTIMULANT, NUTRIENT, AND PESTICIDE | ROBBINS JEFFREY HANSON (US) | 2024-02-29 | — | — | US | disclosed |
| WO-2023154183-A1 | COMPOSITION INCLUDING EFFERVESCENT AGENTS, BIOSTIMULANT, NUTRIENT, AND PESTICIDE | ROBBINS JEFFREY (US) | 2023-08-17 | — | — | WO | disclosed |
| US-20230172194-A1 | COMPOSITION INCLUDING EFFERVESCENT AGENTS, BIOSTIMULANT, NUTRIENT, AND PESTICIDE | ROBBINS JEFFREY HANSON (US) | 2023-06-08 | — | — | US | disclosed |
| US-20220272987-A1 | COMPOSITION INCLUDING EFFERVESCENT AGENTS, BIOSTIMULANT, NUTRIENT, AND PESTICIDE | ROBBINS JEFFREY H (US) | 2022-09-01 | — | — | US | disclosed |
| US-20080167374-A1 | PESTICIDE COMPOSITION AND METHOD OF USE | LOVELAND PRODUCTS, INC. (US) | 2008-07-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250024837-A1 | PESTICIDE SYSTEM | ACHE, PFAS, FPGS | MAPT 4218/4885HPGD 2359/4885SMN1; SMN2 4407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.